SUBJECTIVE RATINGS OF MEDICATION STRENGTH OVER 6 MONTHS IN ELDERLY SUBJECTS WITH MODERATE OR SEVERE INSOMNIA TREATED WITH LEMBOREXANT

被引：0
|
作者：
Drake, Christopher [3 ]
Yardley, Jane [2 ]
Pinner, Kate [2 ]
Moline, Margaret [1 ]
机构：
[1] Eisai Inc, Tokyo, Japan
[2] Eisai Ltd, Tokyo, Japan
[3] Henry Ford Hlth Syst, Sleep Disorders & Res Ctr, Detroit, MI USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR-33
引用
收藏
页码：S74 / S75
页数：3
相关论文
共 24 条
  • [1] Subjective ratings of medication strength of lemborexant over 6 months in subjects with moderate or severe insomnia
    Drake, C.
    Yardley, J.
    Pinner, K.
    Moline, M.
    JOURNAL OF SLEEP RESEARCH, 2022, 31
  • [2] Relationship Between Daytime Functioning and Fatigue Over 6 Months in Lemborexant-Treated Subjects with Insomnia Disorder
    Chepke, Craig
    Yardley, Jane
    Pinner, Kate
    Lundwall, Christie
    Moline, Margaret
    NEUROLOGY, 2023, 100 (17)
  • [3] LONG-TERM PERCEPTION OF MEDICATION EFFECTIVENESS IN ELDERLY SUBJECTS WITH INSOMNIA RECEIVING LEMBOREXANT FOR UP TO 12 MONTHS
    Drake, Christopher
    Yardley, Jane
    Pinner, Kate
    Perdomo, Carlos
    Moline, Margaret
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (04): : S74 - S74
  • [4] CORRELATIONS BETWEEN SLEEP PARAMETERS AND ISI TOTAL SCORE IN SUBJECTS WITH MODERATE TO SEVERE INSOMNIA TREATED WITH LEMBOREXANT
    Moline, Margaret
    Roth, Thomas
    Pinner, Kate
    Yardley, Jane
    Pappadopulos, Elizabeth
    Malhotra, Manoj
    SLEEP, 2022, 45 : A199 - A199
  • [5] Respiratory Safety of Lemborexant in Adult and Elderly Subjects With Moderate to Severe Obstructive Sleep Apnea
    Moline, Margaret
    Cheng, Jocelyn Y.
    Lorch, Daniel
    Hall, Nancy
    Shah, Dhara
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 388 - 388
  • [6] EFFECTIVENESS AND SAFETY OF LEMBOREXANT IN SUBJECTS PREVIOUSLY TREATED WITH PLACEBO FOR 6 MONTHS IN SUNRISE-2
    Yardley, J.
    Inoue, Y.
    Pinner, K.
    Perdomo, C.
    Filippov, G.
    Kubota, N.
    Moline, M.
    SLEEP, 2020, 43 : A181 - A182
  • [7] Effect of Lemborexant on Sleep Architecture in Adult and Elderly Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
    Zammit, Gary
    Cheng, Jocelyn
    Hall, Nancy
    Moline, Margaret
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 400 - 400
  • [8] Respiratory safety of lemborexant in adult and elderly subjects with moderate-to-severe chronic obstructive pulmonary disease
    Cheng, Jocelyn Y.
    Lorch, Daniel
    Hall, Nancy
    Moline, Margaret
    JOURNAL OF SLEEP RESEARCH, 2025, 34 (02)
  • [9] Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study
    Yardley, Jane
    Inoue, Yuichi
    Pinner, Kate
    Perdomo, Carlos
    Kubota, Naoki
    Perlis, Michael L.
    Moline, Margaret
    SLEEP MEDICINE, 2023, 110 : 111 - 119
  • [10] RESPIRATORY SAFETY OF LEMBOREXANT IN ADULT AND ELDERLY SUBJECTS WITH MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY
    Moline, M.
    Cheng, J. Y.
    Lorch, D.
    Hall, N.
    Shah, D.
    SLEEP MEDICINE, 2022, 100 : S135 - S136
123